BofA increased CEO Moyinhan's pay to $35 million in 2024-March 2024-www.financetom.com

BofA increased CEO Moyinhan's pay to $35 million in 2024

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BofA increased CEO Moyinhan's pay to $35 million in 2024

Feb 7, 2025 2:00 PM

Feb 7 (Reuters) - Bank of America Corp ( BAC ) increased

the compensation for Chief Executive Officer Brian Moynihan by

roughly 21% to $35 million for 2024, the lender said in a filing

on Friday.

Previous page： Kaival Brands Shares Plummet After Pricing $6 Million Public Units Offering Next page： Bristol-Myers Squibb's Colorectal Cancer Therapy Receives FDA Approval

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Kaival Brands Shares Plummet After Pricing $6 Million Public Units Offering

Jun 21, 2024

03:25 PM EDT, 06/21/2024 (MT Newswires) -- Kaival Brands Innovations Group ( KAVL ) shares were down nearly 52% in recent trading Friday after the company priced its public offering of about 3.9 million units at $1.53 per unit. The company expects to raise $6 million in gross proceeds from the sale to fund general corporate purposes, working capital and...

Bristol-Myers Squibb's Colorectal Cancer Therapy Receives FDA Approval

Jun 21, 2024

03:13 PM EDT, 06/21/2024 (MT Newswires) -- Bristol-Myers Squibb's ( BMY ) combination therapy of Krazati with cetuximab for colorectal cancer treatment in patients with a specific gene mutation has received approval from the US Food and Drug Administration, the FDA website showed on Friday. Bristol-Myers Squibb ( BMY ) added Krazati to its drug portfolio following the acquisition of...

GM's self-driving Cruise unit to pay $112,500 for delaying crash report

Jun 21, 2024

June 20 (Reuters) - A California regulator said on Thursday it is imposing the maximum penalty of $112,500 on General Motors' ( GM ) self-driving Cruise unit for the company's failure to promptly provide complete information to the commission about a serious crash involving one of its robotaxis last year. WHY IT'S IMPORTANT Cruise along with other self-driving vehicle companies...

US FDA approves Roche's drug for a chronic blood disorder

Jun 21, 2024

June 21 (Reuters) - The U.S. Food and Drug Administration has approved Roche's drug for a chronic blood disorder, according to the regulator's website. ...